Free Trial

Howard Hughes (HHH) Competitors

Howard Hughes logo
$79.69 -1.22 (-1.51%)
Closing price 03:59 PM Eastern
Extended Trading
$79.42 -0.27 (-0.33%)
As of 07:00 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

HHH vs. TSHA, ZG, GLXY, WPC, RGTI, HLI, REG, GLPI, DOC, and AMH

Should you be buying Howard Hughes stock or one of its competitors? The main competitors of Howard Hughes include Taysha Gene Therapies (TSHA), Zillow Group (ZG), Galaxy Digital (GLXY), W.P. Carey (WPC), Rigetti Computing (RGTI), Houlihan Lokey (HLI), Regency Centers (REG), Gaming and Leisure Properties (GLPI), Healthpeak Properties (DOC), and American Homes 4 Rent (AMH).

Howard Hughes vs. Its Competitors

Taysha Gene Therapies (NASDAQ:TSHA) and Howard Hughes (NYSE:HHH) are related companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, earnings, valuation, media sentiment, analyst recommendations, dividends, risk and institutional ownership.

Taysha Gene Therapies presently has a consensus price target of $9.00, indicating a potential upside of 77.17%. Howard Hughes has a consensus price target of $83.33, indicating a potential upside of 4.57%. Given Taysha Gene Therapies' higher possible upside, equities research analysts clearly believe Taysha Gene Therapies is more favorable than Howard Hughes.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Taysha Gene Therapies
1 Sell rating(s)
0 Hold rating(s)
9 Buy rating(s)
0 Strong Buy rating(s)
2.80
Howard Hughes
0 Sell rating(s)
2 Hold rating(s)
2 Buy rating(s)
1 Strong Buy rating(s)
2.80

Howard Hughes has a net margin of 12.85% compared to Taysha Gene Therapies' net margin of -1,144.97%. Howard Hughes' return on equity of 10.51% beat Taysha Gene Therapies' return on equity.

Company Net Margins Return on Equity Return on Assets
Taysha Gene Therapies-1,144.97% -78.44% -44.82%
Howard Hughes 12.85%10.51%3.15%

Taysha Gene Therapies has a beta of 0.99, indicating that its share price is 1% less volatile than the S&P 500. Comparatively, Howard Hughes has a beta of 1.23, indicating that its share price is 23% more volatile than the S&P 500.

Howard Hughes has higher revenue and earnings than Taysha Gene Therapies. Taysha Gene Therapies is trading at a lower price-to-earnings ratio than Howard Hughes, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Taysha Gene Therapies$8.10M171.13-$89.30M-$0.34-14.94
Howard Hughes$1.75B2.70$200.55M$4.5717.44

In the previous week, Taysha Gene Therapies had 2 more articles in the media than Howard Hughes. MarketBeat recorded 5 mentions for Taysha Gene Therapies and 3 mentions for Howard Hughes. Howard Hughes' average media sentiment score of 1.20 beat Taysha Gene Therapies' score of 0.31 indicating that Howard Hughes is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Taysha Gene Therapies
0 Very Positive mention(s)
1 Positive mention(s)
4 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Howard Hughes
3 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

77.7% of Taysha Gene Therapies shares are held by institutional investors. Comparatively, 93.8% of Howard Hughes shares are held by institutional investors. 3.8% of Taysha Gene Therapies shares are held by company insiders. Comparatively, 48.0% of Howard Hughes shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Summary

Howard Hughes beats Taysha Gene Therapies on 12 of the 16 factors compared between the two stocks.

Get Howard Hughes News Delivered to You Automatically

Sign up to receive the latest news and ratings for HHH and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding HHH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

HHH vs. The Competition

MetricHoward HughesREAL ESTATE DEV IndustryFinance SectorNYSE Exchange
Market Cap$4.73B$2.90B$12.54B$21.71B
Dividend YieldN/A2.54%5.56%3.62%
P/E Ratio17.4410.7729.7529.79
Price / Sales2.704.2130.2694.27
Price / Cash8.2329.5822.8024.26
Price / Book1.411.042.234.62
Net Income$200.55M-$84.94M$1.02B$1.01B
7 Day Performance-2.23%4.42%-1.25%-0.79%
1 Month Performance-2.59%2.99%-1.64%0.25%
1 Year Performance3.37%3.64%534.05%11.51%

Howard Hughes Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
HHH
Howard Hughes
3.0916 of 5 stars
$79.69
-1.5%
$83.33
+4.6%
+5.8%$4.73B$1.75B17.44608Positive News
TSHA
Taysha Gene Therapies
2.5083 of 5 stars
$5.05
+3.5%
$9.00
+78.2%
+173.8%$1.33B$8.33M-14.85180Gap Up
ZG
Zillow Group
4.3823 of 5 stars
$66.97
+0.1%
$86.92
+29.8%
+13.8%$16.21B$2.24B-257.586,856
GLXY
Galaxy Digital
1.9558 of 5 stars
$41.23
+4.7%
$36.88
-10.6%
N/A$14.82BN/A0.00528Analyst Forecast
Insider Trade
WPC
W.P. Carey
3.4193 of 5 stars
$67.50
+1.0%
$67.22
-0.4%
+14.5%$14.64B$1.58B44.41190Positive News
RGTI
Rigetti Computing
1.1488 of 5 stars
$54.91
+25.0%
$28.29
-48.5%
+6,851.3%$14.24B$10.79M-72.25160Gap Down
HLI
Houlihan Lokey
4.8904 of 5 stars
$191.69
+1.9%
$212.43
+10.8%
+13.6%$13.22B$2.39B32.271,100Analyst Forecast
Analyst Revision
REG
Regency Centers
4.4089 of 5 stars
$71.48
+1.6%
$79.09
+10.6%
+1.2%$12.78B$1.45B33.40440
GLPI
Gaming and Leisure Properties
4.6509 of 5 stars
$44.33
-0.7%
$52.71
+18.9%
-12.2%$12.63B$1.53B17.1820
DOC
Healthpeak Properties
4.7412 of 5 stars
$17.98
-0.4%
$21.33
+18.7%
-17.1%$12.54B$2.70B74.90200News Coverage
Positive News
Upcoming Earnings
AMH
American Homes 4 Rent
4.7937 of 5 stars
$32.93
+1.2%
$39.57
+20.2%
-13.2%$12.07B$1.73B29.671,730Analyst Forecast

Related Companies and Tools


This page (NYSE:HHH) was last updated on 10/16/2025 by MarketBeat.com Staff
From Our Partners